Keywords: |
protein expression; leukemia; unclassified drug; drug potentiation; nonhuman; neoplasm; cd8+ t lymphocyte; animals; glycoprotein gp 100; ipilimumab; melanoma; antineoplastic activity; drug screening; tumor antigen; viral gene delivery system; prostate cancer; cytokine; immune response; antigens, neoplasm; cancer vaccine; colon cancer; immunogenicity; cancer cell; cd4+ t lymphocyte; neoplasms, experimental; short survey; dna vaccine; interleukin 17; th17 cell; interleukin-17; point mutation; immunosuppressive treatment; virus vector; nras protein; cancer antibody; vesicular stomatitis virus; dna library; sipuleucel t; cytochrome c1; cytochrome c1 plus nras protein plus tyrp1 protein; tyrp1 protein; whole cell vaccine; venezuelan equine encephalomyelitis alphavirus
|